165 related articles for article (PubMed ID: 36195252)
1. Emerging roles of protease-activated receptors in cardiometabolic disorders.
Hara T; Sata M; Fukuda D
J Cardiol; 2023 Apr; 81(4):337-346. PubMed ID: 36195252
[TBL] [Abstract][Full Text] [Related]
2. Roles of Coagulation Proteases and PARs (Protease-Activated Receptors) in Mouse Models of Inflammatory Diseases.
Posma JJ; Grover SP; Hisada Y; Owens AP; Antoniak S; Spronk HM; Mackman N
Arterioscler Thromb Vasc Biol; 2019 Jan; 39(1):13-24. PubMed ID: 30580574
[TBL] [Abstract][Full Text] [Related]
3. Thrombin and activated coagulation factor X stimulate the release of cytokines and fibronectin from nasal polyp fibroblasts
Shimizu S; Tojima I; Takezawa K; Matsumoto K; Kouzaki H; Shimizu T
Am J Rhinol Allergy; 2017 Jan; 31(1):13-18. PubMed ID: 28234145
[TBL] [Abstract][Full Text] [Related]
4. Coagulation Factor Xa Induces Proinflammatory Responses in Cardiac Fibroblasts via Activation of Protease-Activated Receptor-1.
D'Alessandro E; Scaf B; Munts C; van Hunnik A; Trevelyan CJ; Verheule S; Spronk HMH; Turner NA; Ten Cate H; Schotten U; van Nieuwenhoven FA
Cells; 2021 Oct; 10(11):. PubMed ID: 34831181
[TBL] [Abstract][Full Text] [Related]
5. Stimulation of naïve monocytes and PBMCs with coagulation proteases results in thrombin-mediated and PAR-1-dependent cytokine release and cell proliferation in PBMCs only.
Nieuwenhuizen L; Falkenburg WJ; Schutgens RE; Roosendaal G; van Veghel K; Biesma DH; Lafeber FP
Scand J Immunol; 2013 May; 77(5):339-49. PubMed ID: 23421536
[TBL] [Abstract][Full Text] [Related]
6. Coagulation-independent effects of thrombin and Factor Xa: role of protease-activated receptors in pulmonary hypertension.
Joseph C; Berghausen EM; Behringer A; Rauch B; Ten Freyhaus H; Gnatzy-Feik LL; Krause M; Wong DWL; Boor P; Baldus S; Vantler M; Rosenkranz S
Cardiovasc Res; 2022 Dec; 118(16):3225-3238. PubMed ID: 35104324
[TBL] [Abstract][Full Text] [Related]
7. Coagulation cascade proteases and tissue fibrosis.
Chambers RC; Laurent GJ
Biochem Soc Trans; 2002 Apr; 30(2):194-200. PubMed ID: 12023850
[TBL] [Abstract][Full Text] [Related]
8. Role of protease-activated receptors in the vascular system.
Hirano K; Kanaide H
J Atheroscler Thromb; 2003; 10(4):211-25. PubMed ID: 14566084
[TBL] [Abstract][Full Text] [Related]
9. Factor Xa stimulates proinflammatory and profibrotic responses in fibroblasts via protease-activated receptor-2 activation.
Borensztajn K; Stiekema J; Nijmeijer S; Reitsma PH; Peppelenbosch MP; Spek CA
Am J Pathol; 2008 Feb; 172(2):309-20. PubMed ID: 18202198
[TBL] [Abstract][Full Text] [Related]
10. Protease-activated receptors (PARs)--biology and role in cancer invasion and metastasis.
Wojtukiewicz MZ; Hempel D; Sierko E; Tucker SC; Honn KV
Cancer Metastasis Rev; 2015 Dec; 34(4):775-96. PubMed ID: 26573921
[TBL] [Abstract][Full Text] [Related]
11. Macrophage migration inhibitory factor is induced by thrombin and factor Xa in endothelial cells.
Shimizu T; Nishihira J; Watanabe H; Abe R; Honda A; Ishibashi T; Shimizu H
J Biol Chem; 2004 Apr; 279(14):13729-37. PubMed ID: 14736878
[TBL] [Abstract][Full Text] [Related]
12. Blood coagulation factor Xa as an emerging drug target.
Borensztajn K; Spek CA
Expert Opin Ther Targets; 2011 Mar; 15(3):341-9. PubMed ID: 21250873
[TBL] [Abstract][Full Text] [Related]
13. The cardiovascular actions of protease-activated receptors.
Steinberg SF
Mol Pharmacol; 2005 Jan; 67(1):2-11. PubMed ID: 15371558
[TBL] [Abstract][Full Text] [Related]
14. Differential contribution of FXa and thrombin to vascular inflammation in a mouse model of sickle cell disease.
Sparkenbaugh EM; Chantrathammachart P; Mickelson J; van Ryn J; Hebbel RP; Monroe DM; Mackman N; Key NS; Pawlinski R
Blood; 2014 Mar; 123(11):1747-56. PubMed ID: 24449213
[TBL] [Abstract][Full Text] [Related]
15. Protease-Activated Receptor-2 Plays a Critical Role in Vascular Inflammation and Atherosclerosis in Apolipoprotein E-Deficient Mice.
Hara T; Phuong PT; Fukuda D; Yamaguchi K; Murata C; Nishimoto S; Yagi S; Kusunose K; Yamada H; Soeki T; Wakatsuki T; Imoto I; Shimabukuro M; Sata M
Circulation; 2018 Oct; 138(16):1706-1719. PubMed ID: 29700120
[TBL] [Abstract][Full Text] [Related]
16. Emerging roles of Toll-like receptor 9 in cardiometabolic disorders.
Nishimoto S; Fukuda D; Sata M
Inflamm Regen; 2020; 40():18. PubMed ID: 32714475
[TBL] [Abstract][Full Text] [Related]
17. Receptors of the PAR family as a link between blood coagulation and inflammation.
Dugina TN; Kiseleva EV; Chistov IV; Umarova BA; Strukova SM
Biochemistry (Mosc); 2002 Jan; 67(1):65-74. PubMed ID: 11841341
[TBL] [Abstract][Full Text] [Related]
18. A New Concept of Action of Hemostatic Proteases on Inflammation, Neurotoxicity, and Tissue Regeneration.
Gorbacheva LR; Kiseleva EV; Savinkova IG; Strukova SM
Biochemistry (Mosc); 2017 Jul; 82(7):778-790. PubMed ID: 28918742
[TBL] [Abstract][Full Text] [Related]
19. Specificity of coagulation factor signaling.
Ruf W; Dorfleutner A; Riewald M
J Thromb Haemost; 2003 Jul; 1(7):1495-503. PubMed ID: 12871285
[TBL] [Abstract][Full Text] [Related]
20. Role of tissue factor and protease-activated receptors in a mouse model of endotoxemia.
Pawlinski R; Pedersen B; Schabbauer G; Tencati M; Holscher T; Boisvert W; Andrade-Gordon P; Frank RD; Mackman N
Blood; 2004 Feb; 103(4):1342-7. PubMed ID: 14576054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
